#uk-life-sciences

[ follow ]
#pharmaceutical-investment #pharmaceutical-industry #nhs-drug-pricing #us-trade-policy #clinical-trials
UK politics
fromwww.theguardian.com
3 days ago

Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he's menacing Britain | Polly Toynbee

US tariff threats and pricing demands are pushing UK pharmaceutical investment away, undermining British life sciences and straining NHS drug-price negotiations.
#pharmaceutical-investment
more#pharmaceutical-investment
UK politics
fromwww.theguardian.com
1 week ago

US drugmaker Merck scraps 1bn London research centre and cuts 125 science jobs

Merck has scrapped a 1bn London research centre, will discontinue UK discovery research and lay off about 125 scientists while relocating research operations elsewhere.
Canada news
fromwww.theguardian.com
2 months ago

If AstraZeneca goes to the US it will be a major blow for London and Labour

Pascal Soriot is considering moving AstraZeneca's corporate base to the US, impacting the company's UK presence and raising concerns in the scientific community.
[ Load more ]